Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT03963492
Other study ID # Pro2019000453
Secondary ID
Status Suspended
Phase N/A
First received
Last updated
Start date July 1, 2019
Est. completion date February 28, 2023

Study information

Verified date May 2022
Source Rutgers, The State University of New Jersey
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will compare the effectiveness of a traditional, continuous walking rehabilitation program for people with MS to the novel intervention of an intermittent or interval walking rehabilitation program. Half of the participants will receive the continuous walking program while the other half will receive the novel intermittent walking program.


Description:

The typical rehabilitation of walking difficulties for people with MS has included practice walking. In general, this includes training to build walking endurance by having the person with MS walk until he/she becomes tired and needs to stop. Although this model has been used successfully to treat people with other diagnoses, it has limited effectiveness in improving walking ability and endurance in people with MS because of fatigue. Recently, a different model has been considered: intermittent or interval walking training. Interval walking training is organized such that seated rest breaks are intentionally interspersed between walking training bouts that end before the person with MS becomes too tired to continue. Exploratory research has shown that people with MS can walk faster and farther when using interval walking training, and may have more improvements in walking ability and endurance after using interval walking training. This study will compare the effectiveness of the traditional model of continuous walking training to the promising new model of interval walking training. This will help to determine whether interval or continuous walking training is superior in improving walking ability and endurance in people with MS.


Recruitment information / eligibility

Status Suspended
Enrollment 24
Est. completion date February 28, 2023
Est. primary completion date February 28, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - Self-identified difficulty walking - Definitive diagnosis of multiple sclerosis from a neurologist - Signed an approved consent form - Ability to ambulate for unaided for 6-minutes continuously with or without an assistive device (e.g. a cane or brace) - Has not had a multiple sclerosis relapse in the past 6 weeks Exclusion Criteria: - Unwilling or unable to complete assessments - Unwilling or able to complete assessments and or intervention without the use of portable functional electrical stimulation devices - Medical history of concomitant condition unrelated to multiple sclerosis which may impact results including: other neurological conditions including stroke, Parkinson's disease, or orthopedic, or cardiopulmonary conditions that affect walking - Had a major change in exercise habits in the past three months - Individuals reporting change in any disease modifying treatment or steroid use during the past 6 weeks - Unable to walk for 6 minutes continuously without physical assistance - Medical history of unstable angina, uncontrolled cardiac dysrhythmias causing symptoms, symptomatic severe aortic stenosis, uncontrolled symptomatic heart failure, acute pulmonary embolus or pulmonary infarction, history of deep vein thrombosis, acute myocarditis or pericarditis, acute systemic infection, uncontrolled hypertension, and uncontrolled diabetes - Has an abnormal response to exercise - Cannot adhere to protocol - Determined to be unsafe at the discretion of the research team including individuals unwilling to wear safety "gait belt" during testing or not willing to wear proper footwear.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Walking
Participants will undergo training in either the CONT or INT walking interventions 2x/week for 6 weeks for a total plan of 12 training sessions.

Locations

Country Name City State
United States Mandell Center for Multiple Sclerosis - Mount Sinai Rehabilitation Hospital Hartford Connecticut

Sponsors (3)

Lead Sponsor Collaborator
Rutgers, The State University of New Jersey City University of New York, School of Public Health, Mount Sinai Rehabilitation Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in 6-minute Walk Test distance Is a measurement of the distance (in meters) walked at best pace in six minutes. Baseline, 6 weeks (after intervention), and 12 weeks (6-week follow-up)
Secondary Change in 12-item Multiple Sclerosis Walking Scale score A survey that measures a participant's perception of how his/her walking ability is affected by multiple sclerosis. The scale ranges from 0-100 with lower scores representing a lesser impact of multiple sclerosis on the participant's walking ability. There are no subscales. Baseline, 6 weeks (after intervention), and 12 weeks (6-week follow-up)
Secondary Change in Fatigue Severity Scale score A survey that measures a participant's perception of the impact of the symptom of fatigue on a person's ability to participate in life roles. The scale ranges from from 9-63, with lower scores representing a lower impact of fatigue on the ability to perform the activities listed in the scale.There are no subscales. Baseline, 6 weeks (after intervention), and 12 weeks (6-week follow-up)
Secondary Change in Step Length The distance (in centimeters) traversed in one step from initial contact of one foot to the initial contact of the opposite foot. Baseline, 6 weeks (after intervention), and 12 weeks (6-week follow-up)
Secondary Change in Step Time The time (in seconds) taken to complete one step from initial contact of one foot to the initial contact of the opposite foot. Baseline, 6 weeks (after intervention), and 12 weeks (6-week follow-up)
Secondary Change in Stride Velocity The speed with which it takes a person to complete one stride from initial contact of one foot to the next initial contact of the same foot Baseline, 6 weeks (after intervention), and 12 weeks (6-week follow-up)
Secondary Change in Cadence The number of steps (the initial contact of one foot to the initial contact of the opposite foot taken per minute Baseline, 6 weeks (after intervention), and 12 weeks (6-week follow-up)
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT02845635 - MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis